Tenofovir-associated severe bone pain: I cannot walk!

J Int Assoc Physicians AIDS Care (Chic). 2010 Sep-Oct;9(5):328-34. doi: 10.1177/1545109710376595.

Abstract

Two adult patients living with AIDS presented with severe bone pain associated with tenofovir (TDF) use. Both were unable to walk without assistance and were severely restricted in their movement due to the bone pain. Both had mild renal impairment, Fanconi syndrome, and bone mineral density (BMD) loss. Bone pain and inability to walk were reversible with the cessation of TDF and supplementation with Vitamin D(3), calcium, and phosphate. These cases appear to be examples of the severity of BMD loss associated with TDF use and suggest not only attention to renal function with TDF use, but also monitoring of alkaline phosphatase (bone fraction) and plasma phosphorus as indicators of BMD loss.

Publication types

  • Case Reports

MeSH terms

  • Absorptiometry, Photon
  • Adenine / adverse effects
  • Adenine / analogs & derivatives*
  • Adult
  • Alkaline Phosphatase / blood
  • Anti-HIV Agents / adverse effects*
  • Antiretroviral Therapy, Highly Active / methods
  • Bicarbonates / blood
  • Bone Density Conservation Agents / therapeutic use
  • Fanconi Syndrome / chemically induced
  • HIV Infections / drug therapy*
  • HIV-1*
  • Humans
  • Male
  • Middle Aged
  • Mobility Limitation*
  • Organophosphonates / adverse effects*
  • Osteoporosis / chemically induced*
  • Osteoporosis / diagnosis
  • Osteoporosis / drug therapy
  • Osteoporosis / prevention & control
  • Pain / chemically induced*
  • Pain / diagnosis
  • Pain / drug therapy
  • Pain / prevention & control
  • Tenofovir

Substances

  • Anti-HIV Agents
  • Bicarbonates
  • Bone Density Conservation Agents
  • Organophosphonates
  • Tenofovir
  • Alkaline Phosphatase
  • Adenine